Searched for
GLAND PHARMA PROMOTER SALE
IEX shares rise 2% after electricity trading volume jumps 20% YoY to hit record high in AugustIEX shares rose on Friday after the exchange reported record monthly electricity trading volume of 13,938 MUs in August, up 20.2% year-on-y...- Large trade alert! Gland Pharma shares fall 3% after 1.2 crore shares change hands in 2 block deals; promoter Fosun likely sellerGland Pharma shares fell 3% after 1.22 crore shares changed hands in two block deals worth nearly Rs 5,818 crore. Promoter Fosun Pharma Ind...
- Block deal alert! Gland Pharma shares fall 3% as 1.2 crore shares change hands in 2 block deals; promoter Fosun likely sellerGland Pharma shares fell after a significant block deal involving Fosun Pharma Industrial. The company's VSEZ facility received zero USFDA ...
- Stocks in news: HDFC Bank, M&M, Gland Pharma, CreditAccess Grameen and Bharat ForgeIndian benchmark indices extended their losing streak for a fourth consecutive session on Thursday. Nifty 50 fell 0.17% and Sensex declined...
- Drug cos refuse to take sole responsibility for overpricingIndian drugmakers oppose a proposal making them solely liable for medicine overpricing. This regulatory move exempts retail chemists, hospi...
- Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block dealFosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a...
- RPG Life Sciences subsidiary acquires Raghava Life Sciences' API biz for Rs 135 crRPG Active Pharma is acquiring Raghava Life Sciences' API and intermediates business. This strategic move aims to strengthen its integrated...
- Commerce Minister to inaugurate Pharma MachTech & LabNext Expo 2026 at Bharat MandapamSet to kick off on September 7, 2026, in Delhi, the Pharma MachTech & LabNext Expo 2026 aims to position India as a center of excellence fo...
- Monsoon illnesses & flu surge lift drug demandMonsoon illnesses and a significant rise in H1N1 cases are driving a surge in demand for acute therapies and flu vaccines. Sales of anti-in...
- Stocks in news: Reliance Industries, Wipro, Tata Motors, among 9 stocks that will be in focus todayThe BSE Sensex ended at 76,944.28, lower by 12.99 points or 0.02%, as gains in IT, FMCG and select heavyweights helped limit the fall.
- Midcap Street party turns selective as 15 stocks power 50% of rallyIndian midcap and smallcap indices are near record highs currently. A few select stocks are driving most of these significant gains. This c...
- Sun Pharma to extend MFN pricing to US state Medicaid programmesSun Pharma ranks second in US dermatology by prescriptions, with key brands including Ilumya for plaque psoriasis and Winlevi for acne. Rec...
- Daiichi-Ranbaxy case: Delhi HC orders forensic audit into transactions of Fortis, Singh brothersThe Delhi High Court has appointed a forensic auditor to examine transactions. This audit aims to trace the dissipation of Fortis Healthcar...
- Stocks in news: Bharti Airtel, Happiest Minds Technologies, PVR INOX, Milky Mist Dairy and Mankind PharmaIndian equity markets ended lower on August 31, responding to prevailing global economic dynamics. A modest decline in the Nifty50 index br...
- Mankind Pharma divests entire stake in Broadway Hospitality to AKRK ProjectsMankind Pharma has completed the sale of its entire stake in Broadway Hospitality Services. The transaction involved transferring 100 perce...
- Tukaram Mundhe cracks down: Maharashtra FDA cancels licence of Cipla's Pune unit over regulatory violations, Cipla contests actionMaharashtra FDA cancelled Cipla's Pune C&F unit drug sale licenses due to serious storage and recall issues. Inspectors found unauthorized ...
- Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...
- Cipla Pharma license cancellation: FDA withdraws order after HC raps it for going 'overboard'Maharashtra FDA withdrew its order to cancel Cipla Pharma's drug sale license after court intervention. The Bombay High Court criticized th...
- Welspun Corp promoter group, CEO to sell up to Rs 1,417 crore stake via block dealWelspun Corp’s promoter group entity and CEO Vipul Mathur plan to sell up to 63 lakh shares worth Rs 1,417.5 crore through a block deal. Th...
- Gland Pharma appoints Dr Reddy’s senior executive Deepak Sapra as CEOGland Pharma has appointed Deepak Sapra as its new chief executive officer, with his tenure set to begin on November 16, 2026, subject to h...
Load More
